Cargando…
Regulators Associated with Clinical Outcomes Revealed by DNA Methylation Data in Breast Cancer
The regulatory architecture of breast cancer is extraordinarily complex and gene misregulation can occur at many levels, with transcriptional malfunction being a major cause. This dysfunctional process typically involves additional regulatory modulators including DNA methylation. Thus, the interplay...
Autores principales: | Ung, Matthew H., Varn, Frederick S., Lou, Shaoke, Cheng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440643/ https://www.ncbi.nlm.nih.gov/pubmed/25996148 http://dx.doi.org/10.1371/journal.pcbi.1004269 |
Ejemplares similares
-
Integrative analysis of survival-associated gene sets in breast cancer
por: Varn, Frederick S, et al.
Publicado: (2015) -
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
por: Mark, Kenneth M. K., et al.
Publicado: (2017) -
IDEA: Integrated Drug Expression Analysis—Integration of Gene Expression and Clinical Data for the Identification of Therapeutic Candidates
por: Ung, MH, et al.
Publicado: (2015) -
Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis
por: Ung, Matthew H., et al.
Publicado: (2016) -
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
por: Varn, Frederick S., et al.
Publicado: (2016)